首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.
【2h】

Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI.

机译:tex(Ⅲ)texaphyrin:一种可通过MRI检测到的肿瘤选择性放射增敏剂。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gadolinium(III) texaphyrin (Gd-tex2+) is representative of a new class of radiation sensitizers detectable by magnetic resonance imaging (MRI). This porphyrin-like complex has a high electron affinity [E1/2 (red.) approximately = -0.08 V versus normal hydrogen electrode] and forms a long-lived pi-radical cation upon exposure to hydrated electrons, reducing ketyl radicals, or superoxide ions. Consistent with these chemical findings, Gd-tex2+ was found to be an efficient radiation sensitizer in studies carried out with HT29 cells in in vitro as well as in in vivo single and multifraction irradiation studies with a murine mammary carcinoma model. Selective localization of Gd-tex2+ in tumors was confirmed by MRI scanning.
机译:tex(Ⅲ)texaphyrin(Gd-tex2 +)代表了可通过磁共振成像(MRI)检测到的新型辐射敏化剂。这种类似卟啉的配合物具有很高的电子亲和力[E1 / 2(红色),相对于普通氢电极约为-0.08 V],并在暴露于水合电子,还原酮基自由基或超氧化物时形成长寿命的自由基阳离子离子。与这些化学发现一致,在体外用HT29细胞进行的研究以及在鼠乳癌模型的体内单次和多次照射研究中,发现Gd-tex2 +是一种有效的放射增敏剂。 MRI扫描证实了Gd-tex2 +在肿瘤中的选择性定位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号